CD9 and breast carcinoma: We further characterised ultracentrifuged EVs from the different breast cancer cells by Western blot analysis, which confirmed the expression of the tetraspanin CD9 but not of calnexin (Fig. 2c), which are markers of EVs and the endoplasmic reticulum, respectively.